Skip to main content


In some countries, this medicine may only be approved for veterinary use.



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Histamine H₁-receptor antagonist (H₁-antihistaminic)

Neuroleptic agent

Chemical Name

10-(2-Metyl-3-dimetylaminopropyl)phenotiazine (WHO)

Foreign Names

  • Alimemazinum (Latin)
  • Alimemazin (German)
  • Alimémazine (French)
  • Alimemazina (Spanish)

Generic Names

  • Alimemazine (OS: BAN)
  • Alimémazine (OS: DCF)
  • Bayer 1219 (Bayer) (IS)
  • Methylpromazine (IS)
  • RP 6549 (IS)
  • SKF 5277 (IS)
  • Trimeprazine (IS)
  • Alimemazine Hemitartrate (PH: Ph. Eur. 9)
  • Alimemazini hemitartras (PH: Ph. Eur. 9)
  • Trimeprazine (PH: USP 41)
  • Alimemazine Tartrate (OS: BANM, JAN)
  • Trimeprazine Tartrate (IS)
  • Alimémazine (tartrate d') (PH: Ph. Franç. 11)
  • Alimemazine Tartrate (PH: BP 2018, JP XVII)
  • Trimeprazine Tartrate (PH: USP 41)

Brand Names

  • Alimemazine tartrate 10mg Concordia
    Concordia, United Kingdom
  • Alimemazine Tartrate 10mg Zentiva
    Zentiva, United Kingdom
  • Alimemazine Tartrate 30mg/5ml
    Syri, United Kingdom
  • Alimemazine Tartrate 30mg/5ml Zentiva
    Zentiva, United Kingdom
  • Alimemazine Tartrate 7.5mg/5ml
    Syri, United Kingdom
  • Alimemazine Tartrate 7.5mg/5ml Zentiva
    Zentiva, United Kingdom
  • Alimemazine Tartrate P & D
    P & D, Malta
  • Alimezine 0.05%
    Nipro Pharma Nipurofama, Japan
  • Nedeltran
    Sanofi-Aventis Netherlands, Netherlands
  • Panectyl
    ERFA Canada, Canada
  • Temaril P [+ Prednisolone] [veterinary use]
    Zoetis, United States
  • Theralen
    Sanofi, Sweden
  • Theralene
    Sanofi Belgium, Belgium
  • Théralène
    Laboratoire X.O, France
  • Théralène 0.05%
    Laboratoire X.O, France
  • Theralene 10mg
    Sanofi Belgium, Luxembourg
  • Théralène 4%
    Laboratoire X.O, France
  • Trimeprazine Tartrate
    Honten, Taiwan
  • Vallergan
    Sanofi-Aventis, Australia; Sanofi-Aventis, Iceland; Sanofi-Aventis, Norway; Sanofi-Aventis, South Africa
  • Vallergan Forte
    Sanofi-Aventis, New Zealand
  • Variargil
    Italfarmaco, Spain


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.